
Neoadjuvant
PS 0-1
PS 2+
Pancreatic Cancer
Updated: 2017-09-15
Regimens are being updated.
COMMENTS from Pathway Team
Treatment Pathways Index
CH PANC 2: Gem + XRT
CH PANC 3: 5FU + XRT
CH PANC 4: Cape + XRT
CH PANC 8: Gem + nab-Paclitaxel
CH PANC 1: Folfirinox
CH PANC 2: Gem + XRT
CH PANC 8: Gem + nab-Paclitaxel







Adjuvant
Regimens are being updated.
COMMENTS from Pathway Team
Treatment Pathways Index
CH PANC 5: Gem-5FU/XRT-Gem
CH PANC 6: Gemcitabine
CH PANC 7: 5FU/Leucovorin
CH PANC 11: Gem-Cape/XRT-Gem

Pancreatic Cancer
Updated: 2017-09-15

Locally Advanced
PS 0-1
PS 2+
Regimens are being updated.
COMMENTS from Pathway Team
Treatment Pathways Index
CH PANC 1: Folfirinox
CH PANC 2: Gem + XRT
CH PANC 3: 5FU + XRT
CH PANC 4: Cape + XRT
CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel
CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel
CH PANC 2: Gem + XRT
CH PANC 3: 5FU + XRT
CH PANC 4: Cape + XRT
CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel
CH PANC 1: Folfirinox
CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel
CH PANC 9: FOLFOX
CH PANC 10: CapeOx
CH PANC 1: Folfirinox
CH PANC 2: Gem + XRT
CH PANC 3: 5FU + XRT
CH PANC 4: Cape + XRT
CH PANC 9: FOLFOX
CH PANC 10: CapeOx















Pancreatic Cancer
Updated: 2017-09-15

Metastatic or Recurrent
PS 0-1
Mismatch Repair Testing
PS 2+
Regimens are being updated.
COMMENTS from Pathway Team
Treatment Pathways Index
CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel
CH PANC 12: Pembrolizumab
CH PANC 1: Folfirinox
CH PANC 6: Gemcitabine
CH PANC 8: Gem + nab-Paclitaxel











Pancreatic Cancer
Updated: 2017-09-15
Positive
NEGATIVE
(or) No Tissue